A Phase 1, Bioavailability Study of Relatlimab in Combination With Nivolumab
Clinical trial NCT04112498 · COMPLETED
Trial details
- NCT number
- NCT04112498
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2023-02-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.